$SPRO insider trading

Over the last 12 months, Spero Therapeutics insiders reported no purchases and 8 sales totaling $568K across SEC Form 4 filings.

$568K
8
3
0%
Side
$1K$10K$100K$1.0M$10MMay '26JunJulAugNo insider events in this range
Rajavelu Esther
Keutzer Timothy
Mahadevia Ankit

All insider trades

Scroll the table sideways for price, value and marks.

May 4, 2026Rajavelu Esther▼ Sale25,240$2.51$63K-2.5%
Feb 6, 2026Rajavelu Esther▼ Sale87,917$2.36$207K-8%
Feb 6, 2026Keutzer Timothy▼ Sale18,652$2.36$44K-2.5%
Feb 4, 2026Keutzer Timothy▼ Sale46,586$2.17$101K-5.8%
Feb 2, 2026Rajavelu Esther▼ Sale18,442$2.2$41K-1.6%
Nov 7, 2025Rajavelu Esther▼ Sale40,270$2.37$95K-4.4%
Aug 28, 2025Mahadevia Ankit▼ Sale6,572$1.97$13K-0.9%
Aug 28, 2025Keutzer Timothy▼ Sale1,695$1.97$3K-0.2%

Every $SPRO filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Spero Therapeutics filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SPRO feed.

SPRO Insider Trading — Spero Therapeutics Form 4 Buys & Sells | alphai